Amneal Pharmaceuticals, Inc. (AMRX) Ownership — Institutional & Insider Holdings | MarketCI

AM

AMRX

Market Closed

Amneal Pharmaceuticals, Inc.

US

8.30K employees

CEO: Chirag K. Patel

Founded: 2018

$16.34

+$0.00(+NaN%)

Market Cap

5.21B

Beta

1.32

52W Range

N/A

Dividend Yield

0.00%

Big Fish Trades and Ownership

In-depth analysis of ownership patterns and trading activity

Loading Senate trading data...

Explore AMRX

Key metrics and AI-powered insights

Price targets and earnings estimates

Income, balance sheet and cash flow

P/E, DCF and valuation multiples

Institutional and insider holdings

Analyst ratings and news sentiment

AMRX in the Healthcare

Mid Cap

Browse sector stocks →

Browse industry stocks →